MSB 0.46% $1.10 mesoblast limited

Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA, page-149

  1. 2,708 Posts.
    lightbulb Created with Sketch. 168
    Regard this announcement as final acknowledgement from FDA regarding overwhelming approval from OCAD (hopefully got that right, the one that voted 9/10 regarding product approval, and from memory the only member not to vote for it had a conflict of interest) where the FDA required more info, or am I barking up the wrong tree here. Another step forward however you look at it imo.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.10
Change
0.005(0.46%)
Mkt cap ! $1.244B
Open High Low Value Volume
$1.10 $1.12 $1.08 $798.4K 723.9K

Buyers (Bids)

No. Vol. Price($)
9 246041 $1.09
 

Sellers (Offers)

Price($) Vol. No.
$1.10 1767 2
View Market Depth
Last trade - 10.19am 18/06/2024 (20 minute delay) ?
Last
$1.09
  Change
0.005 ( 0.16 %)
Open High Low Volume
$1.10 $1.12 $1.08 132928
Last updated 10.36am 18/06/2024 ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.